Treating cardiovascular or renal diseases
This document provides methods and materials for treating cardiovascular and/or renal diseases. For example, AAV9 vectors designed to express natriuretic polypeptides, nucleic acid molecules encoding natriuretic polypeptides, methods for making AAV9 vectors, and methods for using such vectors or molecules to treat cardiovascular and/or renal diseases are provided.
1. A method for reducing blood pressure in a mammal having renal disease, wherein said method comprises administering an AAV8 or AAV9 vector to said mammal, wherein said vector comprises a nucleic acid sequence encoding a natriuretic polypeptide.
2. The method of claim 1 , wherein said mammal is a human.
3. The method of claim 1 , wherein said natriuretic polypeptide is a human BNP polypeptide.
4. The method of claim 1 , wherein said natriuretic polypeptide is a CDNP polypeptide.
5. The method of claim 1 , wherein said natriuretic polypeptide is a B-CDNP polypeptide.
6. The method of claim 1 , wherein said natriuretic polypeptide is a C-CDNP polypeptide.
7. The method of claim 1 , wherein said vector is an AAV8 vector.
8. The method of claim 1 , wherein said vector is an AAV9 vector.